Similarly, in NSCLC cell line (A549), M4344 and Topotecan altered not the expression of ISGs or other immune genes, but upregulated genes involved in p53 transcriptional gene network and NF‐kB signaling (Figure S4F). The gene discussed is TP53; the disease is non-small cell lung carcinoma.